Animal Foods, Protein, Calcium And Prostate Cancer Risk: The European Prospective Investigation Into Cancer And Nutrition
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology; Nutrition / Diet; Clinical Trials / Drug Trials
Article Date: 13 Jun 2008 - 3:00 PDT
| Patient / Public: | ![]() |
4.5 (2 votes) |
| Healthcare Prof: | ![]() |
3.5 (2 votes) |
UroToday.com - Dr. Allen and a large group of European investigators report their data evaluating intake of protein and the risk of developing prostate cancer (CaP). In the online version of the British Journal of Cancer, they cite other studies that implicate a possible link. Their study used the European Prospective Investigation into Cancer and Nutrition database to study the relationship between diet, lifestyle, environmental factors and cancer. Dietary intake data was obtained by questionnaire and cancer data from cancer registries. Cox regression was used for analysis and separate analyses were conducted for localized and advanced disease, and also for low-grade and high-grade cancer.
A total of 2,722 men were diagnosed with CaP from a total of 142,520 participants at an average of 8.7 years of follow-up. The median age at diagnosis was 66 years. Protein intake was derived from meat in 32%, cereals in 18%, cheese in 9%, and milk in 7%. Dietary calcium was largely from dairy products (53%). There was a strong correlation between dairy protein and dairy calcium intake. There was no association between meat, fish or eggs and risk of CaP. Dairy products and yoghurt had an increased risk (HR1.17 for the highest vs. lowest fifth of intake). A similar risk was found for total dietary calcium intake and calcium intake from dairy foods. Calcium from non-dairy foods was not associated with CaP risk. An increment of 35g/day of dairy protein was associated with an HR of 1.32. No statistical difference was found for localized vs. advanced disease but there was an association for high-grade CaP (HR1.76).
Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Tjønneland A, Johnsen NF, Overvad K, Linseisen J, Rohrmann S, Boeing H, Pischon T, Bueno-de-Mesquita HB, Kiemeney L, Tagliabue G, Palli D, Vineis P, Tumino R, Trichopoulou A, Kassapa C, Trichopoulos D, Ardanaz E, Larrañaga N, Tormo MJ, González CA, Quirós JR, Sánchez MJ, Bingham S, Khaw KT, Manjer J, Berglund G, Stattin P, Hallmans G, Slimani N, Ferrari P, Rinaldi S, Riboli E
Br J Cancer. 2008 Apr 1 (Epub ahead of print) doi: 10.1038/sj.bjc.6604331
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/111090.php>
APA
http://www.medicalnewstoday.com/releases/111090.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




